Insights

My Treatment Approach: Metastatic Colorectal Cancer

November 30th 2021

Optimizing Treatment for Relapsed Refractory Follicular Lymphoma and Marginal Zone Lymphoma

November 22nd 2021

Targeting FGFR Mutations in Metastatic Urothelial Cancer

November 10th 2021

Major Advances in NSCLC: EGFR Exon 20 Insertion Mutations

October 28th 2021

Advances in Hormone Receptor Positive Metastatic Breast Cancer

October 27th 2021

Targetable Gene Rearrangements in Advanced Lung Cancer: Optimized Testing and Management

October 11th 2021

The New Era of Treating Myelofibrosis

August 30th 2021

Treatment-Related Interstitial Lung Disease

August 25th 2021

Neuroendocrine Tumors: Targeted Therapies

August 20th 2021

Management of Myelodysplastic Syndromes in High-Risk Patients

August 5th 2021

Therapeutic Advances for Patients With Chronic Lymphocytic Leukemia

July 30th 2021

Acute Lymphoblastic Leukemia: Treatment Strategies and Considerations

July 27th 2021

Update on Immuno-Oncology Based Therapy for mCRC

July 27th 2021

The Evolving Treatment Landscape of Metastatic Gastric and Gastroesophageal Junction Cancers

July 12th 2021

Recent Updates in Relapsed or Refractory Multiple Myeloma

June 4th 2021

Update on EGFR Antibodies in mCRC

May 25th 2021

Triple-Class Refractory Multiple Myeloma

May 4th 2021

New Targets to Improve Patient Outcomes in MZL and FL

April 20th 2021

Exploring Immunotherapy Combinations in Endometrial Cancer

April 14th 2021

Graft Versus Host Disease

April 13th 2021
<>
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights.
All rights reserved.